D
DoubleRainbow Biosciences
Transformative technologies to unleash the power of chemistry
About DoubleRainbow Biosciences
Double Rainbow Bio harnesses cutting-edge advancements in genomics, metabolomics, and synthetic biology to revolutionize the manufacturing of natural products. These products are essential for a variety of consumer and industrial applications that support human health and well-being. The company operates in the biotechnology sector, focusing on clients who require sustainable and innovative solutions for natural product manufacturing. Double Rainbow Bio's business model involves leveraging scientific expertise to create high-value natural products, thereby generating revenue through partnerships and product sales. The company is committed to balancing ancient wisdom with modern technology, aiming to improve both human health and planetary sustainability.
Source: Dealroom company dataNews
Open roles
DoubleRainbow Biosciences in the Lexington ecosystem
The DoubleRainbow Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Beda Pharmaceuticals
Gaorong Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about DoubleRainbow Biosciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See DoubleRainbow Biosciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

